Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Elizabeth Ramirez De Arellano

Diagnostic Radiology Middletown, NY Medical Doctor

NPI 1235155904 CMS profile 1081536

707 E Main St, Radiologic Associates, Pc, Middletown, NY 10940

Open in the dashboard

General payments

$296,720

313 records reported · program years 2019–2025

Research payments

$292,650

Paid to them · 37 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Elizabeth Ramirez De Arellano of Middletown, NY is reported in the CMS Open Payments database as having received $296,720 across 313 general payments and $292,650 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 Research $30,975 5
2024 Research $20,730 4
2023 Research $114,720 6
2022 Research $23,490 6
2021 General $91,855 123
2021 Research $26,325 6
2020 General $124,540 122
2020 Research $23,850 5
2019 General $80,325 68
2019 Research $52,560 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Elizabeth Ramirez De Arellano
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Elizabeth Ramirez De Arellano were reported at $0. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Elizabeth Ramirez De Arellano Diagnostic Radiology median Middle half National median
2019 $80,325 $108 $29–$318 $163
2020 $124,540 $65 $21–$252 $114
2021 $91,855 $92 $24–$292 $132
2022 $0 $104 $29–$294 $149
2023 $0 $110 $29–$337 $160
2024 $0 $113 $30–$356 $164
2025 $0 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Merck Sharp & Dohme Corporation $283,620 292 payments
  2. Pfizer Inc. $13,100 21 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $296,720 313 payments
Products named General payments · program years 2019–2025
  1. KEYTRUDA $168,180 150 payments
  2. LENVIMA $112,935 126 payments
  3. IBRANCE $13,100 21 payments
  4. MK-7339 $1,260 7 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. E.R. Squibb & Sons, L.L.C. $254,265 29 payments
  2. Eli Lilly and Company $38,385 8 payments

Records

350 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record